Sanofi Pasteur SA

On October 4, at the Biotechmed forum, Nanolek and Sanofi signed an agreement for localization of packaging and quality control of meningococcal vaccine Menaktra at the factory in the Kirov Region. Nanolek’s site has already received a registration certificate for the vaccine. Sanofi announced that they plan to produce 2.2 to 3.5 million doses of Menaktra at the partner's site annually. According to Frederic Jumel, General Manager Eurasia, such volume is sufficient to cover the existing demand for the medicine. The partners did not disclose the amount of project investment.

04 October 2021
Kommersant

The first batch of ultra short acting insulins, including 1 million cartridges, produced at the Sanofi-Aventis East plant has arrived in Germany for further distribution throughout the Europe.

11 September 2020
https://oreltimes.ru/
Investor
Oryol Region

Investor profile

Sanofi Pasteur SA

France